A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age

PHASE2CompletedINTERVENTIONAL

Enrollment

365

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

June 25, 2018

Study Completion Date

June 25, 2018

Conditions

Group B Streptococcal Infections

Interventions

BIOLOGICAL

Multivalent group B streptococcus vaccine

Various formulations at three dose levels

BIOLOGICAL

Placebo

Saline Control

Trial Locations (4)

Clinical Research Atlanta, Stockbridge

Kentucky Pediatric / Adult Research, Bardstown

J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City

J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City